BBR Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.51M Buy
1,641
+12
+0.7% +$12.2K 0.08% 85
2025
Q4
$1.75M Sell
1,629
-11
-0.7% -$10.5K 0.09% 85
2025
Q3
$1.25M Buy
1,640
+37
+2% +$27.5K 0.07% 97
2025
Q2
$1.25M Sell
1,603
-13
-0.8% -$10.1K 0.08% 96
2025
Q1
$1.33M Sell
1,616
-230
-12% -$191K 0.09% 80
2024
Q4
$1.43M Buy
1,846
+250
+16% +$207K 0.1% 78
2024
Q3
$1.41M Sell
1,596
-63
-4% -$56.6K 0.11% 66
2024
Q2
$1.5M Sell
1,659
-829
-33% -$663K 0.12% 61
2024
Q1
$1.94M Sell
2,488
-132
-5% -$93.9K 0.16% 62
2023
Q4
$1.53M Sell
2,620
-530
-17% -$309K 0.16% 56
2023
Q3
$1.69M Buy
3,150
+934
+42% +$481K 0.19% 49
2023
Q2
$1.04M Buy
2,216
+138
+7% +$57.9K 0.12% 63
2023
Q1
$714K Sell
2,078
-669
-24% -$226K 0.08% 83
2022
Q4
$1M Buy
2,747
+237
+9% +$84K 0.11% 67
2022
Q3
$812K Sell
2,510
-299
-11% -$94.7K 0.1% 81
2022
Q2
$911K Buy
2,809
+28
+1% +$8.4K 0.11% 88
2022
Q1
$796K Buy
2,781
+1,000
+56% +$257K 0.08% 109
2021
Q4
$492K Sell
1,781
-74
-4% -$18.8K 0.06% 121
2021
Q3
$429K Sell
1,855
-82
-4% -$20.2K 0.04% 139
2021
Q2
$445K Sell
1,937
-112
-5% -$22.5K 0.04% 124
2021
Q1
$383K Sell
2,049
-1
-0% -$196 0.03% 147
2020
Q4
$346K Buy
2,050
+75
+4% +$11.2K 0.03% 135
2020
Q3
$292K Buy
+1,975
New +$306K 0.03% 143

Other funds holding LLY

BBR Partners's LLY Position: Q1 2026 in Review

BBR Partners increased its Eli Lilly (LLY) stake by 0.74% in Q1 2026, buying an estimated $12.2K and bringing the position to 1,641 shares worth $1.51M. The position accounts for 0.08% of the portfolio, ranked #85.

BBR Partners first reported a position in LLY in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.94M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BBR Partners held 1,641 shares of Eli Lilly worth $1.51M as of Q1 2026.
  • BBR Partners bought 12 Eli Lilly shares in Q1 2026, an estimated $12.2K.
  • Eli Lilly made up 0.08% of BBR Partners's portfolio in Q1 2026, its #85 holding.
  • BBR Partners first reported a position in Eli Lilly in Q3 2020 and has held it in 23 quarters since.
  • BBR Partners's Eli Lilly position peaked at $1.94M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BBR Partners's 13F filing for Q1 2026, filed 12 May 2026.